Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-060115

Chief Scientific Officer sold 11,685 shares at an average $32.95 ($385,018)

  • Chief Scientific Officer acquired 11,685 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

ROBINS HARLAN S · Chief Scientific Officer

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2021-10-06 Exercise or conversion : show line 1 in the form +3,895 $6.32 $24,616 73,255 D
2021-10-06 Sale : show line 2 in the form −3,895 $32.27 $125,692 69,360 D
2021-10-07 Exercise or conversion : show line 3 in the form +3,895 $6.32 $24,616 73,255 D
2021-10-07 Sale : show line 4 in the form −200 $32.50 $6,500 73,055 D
2021-10-07 Sale : show line 5 in the form −3,695 $33.68 $124,448 69,360 D
2021-10-08 Exercise or conversion : show line 6 in the form +3,895 $6.32 $24,616 73,255 D
2021-10-08 Sale : show line 7 in the form −3,895 $32.96 $128,379 69,360 D
Open-market sales · 11,685 sh · avg $32.95 · $385,018

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2021-10-06 Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) −3,895 77,900 D
2021-10-07 Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) −3,895 74,005 D
2021-10-08 Exercise or conversion : show line 10 in the form Stock Option (Right to Buy) −3,895 70,110 D
Loading xslF345X03/doc4.xml…